IGM BIOSCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.335 USD | +0.06% |
|
-9.69% | +0.42% |
| 05-09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
| 05-08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IGM BIOSCIENCES, INC. | Bio Therapeutic Drugs | +0.12% | -9.69% | +0.42% | -21.20% | - | 492M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IGMS Stock
- Charts IGM Biosciences, Inc.
- Comparison Chart